UBS Maintains Buy on Omega Healthcare Invts, Lowers Price Target to $52
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and lowers the price target from $54 to $52.
Stocks · News reference
8-K filing — OMEGA HEALTHCARE INVESTORS INC (OHI)
Filed: 2026-10-05 AccNo: 0001104659-26-113450 Size: 240 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Underweight on Omega Healthcare Invts, Lowers Price Target to $48
Barclays analyst Richard Hightower maintains Omega Healthcare Invts (NYSE:OHI) with a Underweight and lowers the price target from $50 to $48.
Omega Transitions Operations Of 32 Florida Skilled Nursing Facilities From Airamid To PACS Group; Year-One Rent Up $26.1M, $90M One-Time Expense